Your browser doesn't support javascript.
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Matsumura, Ayako; Katsuki, Kengo; Akimoto, Masahiro; Sakuma, Takayuki; Nakajima, Yuki; Miyazaki, Takuya; Fujisawa, Shin; Nakajima, Hideaki.
  • Matsumura A; Department of Hematology, Yokohama City University Medical Center.
  • Katsuki K; Department of Hematology, Yokohama City University Medical Center.
  • Akimoto M; Department of Hematology, Yokohama City University Medical Center.
  • Sakuma T; Department of Hematology, Yokohama City University Medical Center.
  • Nakajima Y; Department of Hematology, Yokohama City University Medical Center.
  • Miyazaki T; Department of Hematology, Yokohama City University Medical Center.
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center.
  • Nakajima H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine.
Rinsho Ketsueki ; 62(11): 1639-1642, 2021.
Article in Japanese | MEDLINE | ID: covidwho-1555777
ABSTRACT
Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic until today, but treatment options remain limited. COVID-19 vaccination is expected to decrease the number of patients with COVID-19 worldwide. In Japan, two types of mRNA COVID-19 vaccine, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have been approved and administered. However, their side effects remain poorly elucidated. This paper presents two cases of immune thrombocytopenia (ITP) after BNT162b2 mRNA COVID-19 vaccination. Whether or not ITP is triggered by the vaccination or not is difficult to identify. Further investigation with a large number of cases is warranted to clarify the side effects of BNT162b2 mRNA COVID-19 vaccination.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / COVID-19 Topics: Vaccines Limits: Humans Language: Japanese Journal: Rinsho Ketsueki Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / COVID-19 Topics: Vaccines Limits: Humans Language: Japanese Journal: Rinsho Ketsueki Year: 2021 Document Type: Article